BNTX
$95.1
Revenue | $1518.9Mn |
Net Profits | $-28.7Mn |
Net Profit Margins | -1.89% |
Biontech Se’s revenue jumped 22.02% since last year same period to $1518.9Mn in the Q3 2025. On a quarterly growth basis, Biontech Se has generated 482.4% jump in its revenue since last 3-months.
Biontech Se’s net profit fell -114.49% since last year same period to $-28.7Mn in the Q3 2025. On a quarterly growth basis, Biontech Se has generated 92.58% jump in its net profits since last 3-months.
Biontech Se’s net profit margin fell -111.87% since last year same period to -1.89% in the Q3 2025. On a quarterly growth basis, Biontech Se has generated 98.73% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a -347% fall from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at -0.25.
Earning Per Share (EPS) | 0 |
Biontech Se’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Biontech Se has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-04 | -1.41 | -1.6 | -13.48% |
2026-03-10 | -0.25 | 0 | 100% |
2025-03-31 | -2.35 | -1.82 | 22.42% |
2025-11-03 | 0.1 | -0.12 | -220% |